Advertisement

Topics

FDA approves Merck drug to prevent post-transplant infections

17:33 EST 9 Nov 2017 | pharmaphorum

The FDA has approved a new Merck & Co drug to prevent infections in patients who have had stem cell transplants. Cytomegalovirus (CMV) infection can cause major complications after stem cell transplants, and while there are already antiviral t...

Original Article: FDA approves Merck drug to prevent post-transplant infections

NEXT ARTICLE

More From BioPortfolio on "FDA approves Merck drug to prevent post-transplant infections"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...